Ligand validation:6Q9W

O4B: 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Q9W_O4B_A_204	73%	70%	0.099	0.926	0.75	0.4	-	-	0	0	100%	1
6Q9W_O4B_B_204	53%	75%	0.128	0.889	0.81	0.19	-	-	1	0	100%	1
6Q9W_O4B_A_203	25%	74%	0.174	0.808	0.86	0.16	-	-	1	0	100%	1
6Q9W_O4B_B_203	22%	68%	0.163	0.777	0.81	0.42	-	-	0	0	100%	1
6Q9S_O4B_B_202	78%	71%	0.119	0.961	0.79	0.33	-	-	0	0	100%	1
3WUR_O4B_B_202	94%	44%	0.067	0.964	1.23	0.96	1	1	0	0	100%	1
5ZW2_O4B_A_503	92%	64%	0.08	0.969	0.59	0.78	-	-	0	0	100%	1
3WH0_O4B_A_202	81%	28%	0.083	0.935	1.67	1.25	2	2	1	0	100%	1
7VEL_O4B_A_602	73%	72%	0.109	0.936	0.55	0.53	-	-	0	0	100%	1
4BEI_O4B_A_1272	70%	57%	0.134	0.952	0.92	0.76	-	-	9	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.